Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Lueftner, Diana; Bartsch, Rupert; Breitenstein, Urs et al.
Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+/ HR+ early breast cancer (eBC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 20-21
Anic, K.; Schmidt, M. W.; Rohde, L. et al.
Intermittent fasting affects quality of life and fatigue - results of a prospective cohort studyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E42-E42
Löwe, A; Hasenburg, A; Almstedt, K
Langzeitüberleben bei Patientinnen mit gynäkologischen Malignomen – Wer sind sie, kann man sie vorhersagen und wie können wir ihre Lebensqualität verbessern?Frauenarzt. Bd. 63. H. 11. 2022 S. 730-735
Brackmann, Lara Kim; Foraita, Ronja; Schwarz, Heike et al.
Late health effects and changes in lifestyle factors after cancer in childhood with and without subsequent second primary cancers - the KiKme case-control studyFRONTIERS IN ONCOLOGY. Bd. 12. 2022
Beutel, M.; Brahler, E.; Wild, P. et al.
Loneliness as a risk factor for suicidal ideation and anxiety in cancer survivor populationsJOURNAL OF PSYCHOSOMATIC RESEARCH. Bd. 157. 2022
Aleshchenko, E.; Swart, E.; Spix, C. et al.
Long-term care, care needs and wellbeing of individuals after cancer in childhood or adolescence (VersKiK): study protocol of a large scale multi-methods non-interventional studyBMC HEALTH SERVICES RESEARCH. Bd. 22. H. 1. 2022
Platzbecker, Uwe; Goetze, Katharina S.; Kiewe, Philipp et al.
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 33. 2022 S. 3800-+
Ferreri, Andres J. M.; Cwynarski, Kate; Pulczynski, Elisa et al.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialLEUKEMIA. Bd. 36. H. 7. 2022 S. 1870-1878
Dreyling, Martin; Goy, Andre; Hess, Georg et al.
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-upHEMASPHERE. Bd. 6. H. 5. 2022
Almstedt, Katrin; Heimes, Anne-Sophie; Kappenberg, Franziska et al.
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancerEUROPEAN JOURNAL OF CANCER. Bd. 173. 2022 S. 10-19